galantamine has been researched along with 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Addorisio, ME; Al-Abed, Y; Al-Onaizi, MA; Chavan, SS; Gros, R; Lehner, KR; Levine, Y; Metz, CN; Nathanson, NM; Olofsson, PS; Pavlov, VA; Prado, MAM; Prado, VF; Roy, A; Silverman, HA; Tracey, KJ | 1 |
1 other study(ies) available for galantamine and 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
Article | Year |
---|---|
Forebrain Cholinergic Signaling Regulates Innate Immune Responses and Inflammation.
Topics: Acetylcholine; Animals; Anti-Inflammatory Agents; Cholinergic Agonists; Cholinesterase Inhibitors; Cytokines; Endotoxemia; Galantamine; Immunity, Innate; Inflammation; Male; Mice, Inbred C57BL; Mice, Transgenic; Prosencephalon; Quinolines; Receptor, Muscarinic M1; Vesicular Acetylcholine Transport Proteins | 2019 |